<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879604</url>
  </required_header>
  <id_info>
    <org_study_id>UF 9679</org_study_id>
    <nct_id>NCT02879604</nct_id>
  </id_info>
  <brief_title>Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia</brief_title>
  <acronym>Grecco</acronym>
  <official_title>Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Assistances publiques hopitaux de Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Assistances publiques hopitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Louis Mourier, Colombes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Charles Perrens, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHRU Strasbourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Center Alpes-Isère</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier le Vinatier, Bron</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratoire Santé Publique - Faculté de Médecine - Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondation FondaMental</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Significant cognitive impairment (executive functions, memory, attention) is common in
      schizophrenia affecting up to 80% of patients. But pharmacological treatments (typical and
      atypical antipsychotic) do not have impact on cognitive functioning. For over 20 years,
      alternative non-pharmacological therapeutics have been developed in schizophrenia. These
      techniques called cognitive remediation specifically target cognitive deficits. The first
      cognitive remediation available for patients was designed to stimulate new learning, or
      relearning, of cognitive tasks, and thus to improve certain deficient domains. These
      procedures were efficient in improving cognition as measured by neurocognitive tests but
      their impact on functioning and daily life was weak. In a second time, compensatory
      remediation has been developed. Compensatory approaches seek to make improvements in the
      patient's functioning by avoiding areas of impairment and recruiting other intact cognitive
      domains or by creating a supportive external environment. In recent meta-analysis
      compensatory remediation has larger effect-size than classical cognitive remediation, with an
      impact on patients psychosocial functioning. Recently, Dr E. Twamley (University of
      California) developed and tested a group-based, manualized, compensatory cognitive training
      intervention.

      Compensatory cognitive training (CCT) is a low-tech, brief intervention and is easily
      transposable in community care. Our team translated this method into French. The
      investigators planned a cost -utility study between CCT and treatment as usual in
      schizophrenia patients with less than 10 years of evolution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will take place over 3 years with a recruitment period of 18 months. After
      verification of the eligibility criteria and signature of the consent, the patients will be
      divided into 2 groups by randomization: the intervention group and the control group. The
      duration of participation of the subjects will be 12 months. Assessments are available in 4
      steps (V1 at inclusion, V2 at 3 months, V3 at 6 months and V4 at 12 months). These visits
      include an assessment of the functioning of patients, symptomatology, quality of life,
      treatment and care received at all visits, occupational activity and cognitive assessment and
      social knowledge at V1 and V4.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cost-utility questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>Cost difference between the 2 group of patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functioning questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>FROGS, Functional Remission of General Schizophrenia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Compensatory cognitive training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Compensatory cognitive training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>usual treatment for shizophrenai</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Compensatory cognitive training</intervention_name>
    <description>In addition to the usual care, method of compensatory cognitive remediation</description>
    <arm_group_label>Compensatory cognitive training</arm_group_label>
    <other_name>CCT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual</intervention_name>
    <description>Usual care</description>
    <arm_group_label>usual treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnostic with schizophrénie

          -  Less than 10 years of the evolution of the disease

        Exclusion Criteria:

          -  History of severe cranial trauma and / or neurological pathology with cognitive
             impairment

          -  Ongoing participation in another study for treatment of negative or cognitive symptoms

          -  Ongoing participation in a study on management in psychotherapy for cognitive
             disorders and negative symptoms
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Delphine Capdevielle, MD-PhD</last_name>
    <phone>033467339727</phone>
    <email>d-capdevielle@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Raffard, PhD</last_name>
    <phone>033467339702</phone>
    <email>s-raffard@chu-montpellier.fr</email>
  </overall_contact_backup>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>August 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2016</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cognitive remediation, cost-effectiveness analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

